Do you have the same question? Follow this Question
Nov 18, 2025 - 01:12 PM
We’ve provided several answers to questions related to Euflexxa (Sodium Hyaluronate) , see some other helpful Q&A related to this product.
Question: What is the PubChem CID for sodium hyaluronate?
Answer: The PubChem CID is 24759. PubChem CID is a unique identifier for chemicals, helpful for those seeking detailed scientific information.
Question: What should be done if the product is expired or the package is damaged?
Answer: It should not be used if expired, damaged, or opened. Using only intact and in-date products ensures safety and effectiveness, minimizing the risk of contamination or reduced efficacy.
Question: What are some common side effects?
Answer: Common side effects include joint pain, musculoskeletal pain, back pain, joint swelling, and pain in the legs or arms. Knowing potential side effects helps customers make informed decisions and recognize when to seek medical advice.
Question: What is the bioavailability of this product?
Answer: The bioavailability is local (intra-articular), with minimal systemic absorption. Localized bioavailability reduces the risk of side effects elsewhere in the body, making it a safer option for joint-specific issues.
Question: What is the legal status of the product?
Answer: It is available by prescription only (Rx). This requirement ensures that the product is used appropriately under medical supervision, which is especially important for intra-articular treatments.
Question: What is the recommended route of administration?
Answer: It is administered via intra-articular injection, meaning it is injected directly into the joint space. Intra-articular administration allows the medication to act exactly where it's needed, providing targeted relief for knee pain.
